Abstract
Clinical decision-making in cardiology requires accurate estimates of the efficacy of diagnostic and therapeutic procedures. Defined as the quantitative integration of results from different studies on the same scientific question, meta-analyses are well-suited to summarize the evidence on the efficacy of clinical interventions. Meta-analyses aim at obtaining combined estimates of effect using all relevant information in a systematic fashion, complementing narrative reviews and expert committee reports. In this paper, the advantages and limitations of meta-analyses and their usefulness in clinical decision making in cardiology are illustrated using three recent examples in the literature - i.e. use of β-blockers in secondary prevention of ischemic heart disease, intravenous streptokinase in acute myocardial infarction and fish intake in primary prevention of cardiovascular mortality. The steps to follow when conducting a meta-analysis are also discussed. Finally, a list of the most important meta-analyses in cardiology published to date is included for easy reference.
Translated title of the contribution | Meta-analysis: Its role in clinical decision-making in cardiology |
---|---|
Original language | Spanish |
Pages (from-to) | 509-517 |
Number of pages | 9 |
Journal | Revista Espanola de Cardiologia |
Volume | 47 |
Issue number | 8 |
State | Published - 1994 |
Keywords
- clinical decision-making
- efficacy of cardiological procedures
- health technology assessment
- meta-analysis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine